urgent urinary incontinency. Urgency of urination
Conditions
Interventions
Intervention 1: Intervention group: Oral pearl Vitamin D 50,000 units weekly for up to 8 weeks. Intervention 2: Control group: Oral placebo once a week for up to 8 weeks.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: Menopausal women between 50 and 80 years of age Serum level of vitamin D3 below 30ng / ml Urgent urinary incontinence of any degree Written informed consent for participation in the study
Exclusion criteria
Exclusion criteria: Any underlying condition that impairs vitamin D absorption, such as IBD and gastric bypass surgery Chronic liver or kidney disease Any neurological disorder that affects the urinary system such as MS, degenerative muscle disorders, CVA, and Spinal cord injury Diabetes History of chronic cough or chronic constipation History of vesiculovaginal fistula Progesterone and estrogen supplement in the last six months Urinary tract infection during the test Severe bladder prolapse (stages 3 and 4 cystocele and apical). Patients using diuretics Not knowing Persian language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: Vitamin D level before and after 8 weeks of vitamin D administration. Method of measurement: Serum Level.;Severity of urinary incontinence symptoms before and after treatment. Timepoint: Before and after treatment. Method of measurement: Modified LUTS EPINCONT questionnaire (based on total incontinence frequency and leakage volume).;The degree of disturbance in the patient's quality of life due to urinary incontinency (before and after treatment). Timepoint: At the beginning of the study and after the end of treatment. Method of measurement: Modified LUTS EPINCONT questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Arjmand
Shahid Beheshti University of Medical Sciences
Outcome results
None listed